Meril Diagnostics
Rapid Diagnostic Test
· Rapid Diagnostic Test
MERISCREEN Drug of Abuse (DOA) Rapid Test
| Technical Blueprint Specification | Clinical Value |
|---|---|
detection_time | Minutes (typically 5-10) |
storage_temperature | 2-30°C |
shelf_life | 24 months |
format
Lateral Flow Immunoassay
sample_type
Urine
cutoff_values
Vary by drug; refer to package insert
Primary Material
Individually pouched test devices, disposable pipettes, package insert
The MERISCREEN Drug of Abuse (DOA) Rapid Test is a premium medical device manufactured by Meril Diagnostics for the Rapid Diagnostic Test category.
This product is manufactured by Meril Diagnostics and is distributed by Agile Healthcare across all districts of Telangana.
Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the MERISCREEN Drug of Abuse (DOA) Rapid Test, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.
The MERISCREEN Drug of Abuse (DOA) Rapid Test is constructed using Individually pouched test devices, disposable pipettes, package insert, ensuring high biocompatibility and durability.